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Abstract
Background—S-nitrosylation of mitochondrial enzymes involved in energy transfer under 
nitrosative stress may result in ATP deficiency. We investigated whether α-lipoic acid, a powerful 
antioxidant, could alleviate nitrosative stress by regulating S-nitrosylation, which could result in 
retaining the mitochondrial enzyme activity.
Methods—In this study, we have identified the S-nitrosylated forms of subunit 1 of 
dihydrolipoyllysine succinyltransferase (complex III), and subunit 2 of the α-ketoglutarate 
dehydrogenase complex by implementing a fluorescence-based differential quantitative 
proteomics method.
Results—We found that the activities of these two mitochondrial enzymes were partially but 
reversibly inhibited by S-nitrosylation in cultured endothelial cells, and that their activities were 
partially restored by supplementation of α-lipoic acid. We show that protein S-nitrosylation affects 
the activity of mitochondrial enzymes that are central to energy supply, and that α-lipoic acid 
protects mitochondrial enzymes by altering S-nitrosylation levels.
Conclusions—Inhibiting protein S-nitrosylation with α-lipoic acid seems to be a protective 
mechanism against nitrosative stress.
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General significance—Identification and characterization of these new protein targets should 
contribute to expanding the therapeutic power of α-lipoic acid and to a better understanding of the 
underlying antioxidant mechanisms.
Keywords
α-Lipoic acid; antioxidant; nitric oxide (NO); nitrosative stress (NS); reactive oxigen species 
(ROS); mitochondria; S-nitrosylation; ATP
1. Introduction
Nitric oxide (NO) is a soluble and highly diffusible gas generated by a wide variety of cell 
types including vascular endothelial cells. NO plays an important role in endothelium-
derived smooth muscle relaxation [1]. Excess production of endogenous NO under 
inflammatory conditions can be toxic to vascular endothelial cells [2]. Unregulated NO 
production leads to an increase in Reactive Nitrogen Species (RNS) resulting in nitrosative 
stress (NS), which may give rise to significant pathological outcomes including cellular 
injury and disease [3]. Specifically, NS is involved in the pathogenesis of low-grade chronic 
inflammatory-associated diseases such as atherosclerosis and type 2 diabetes [4, 5]. A better 
understanding of NS-associated underlying mechanisms may help improve therapeutic 
outcomes for these diseases.
Evidence shows that NO regulates protein function via S-nitrosylation, a reversible redox 
post-translational modification that adds an NO group to a reactive cysteine residue in 
regulatory proteins [6]. In recent years, protein S-nitrosylation has received much attention 
as an ubiquitous regulatory strategy for multiple biological processes [7, 8, 9]. NO-induced 
protein S-nitrosylation results in the modulation of active-site thiol and disulfide formation 
that could either inhibit or enhance the catalytic activity of redox-sensitive enzymes [10]. 
Some investigations have suggested that S-nitrosylation is involved in both normal and 
abnormal vascular function [6], including regulation of key metabolic pathways [11].
Endothelial cells form the inner cellular lining of blood vessels and play a key role in 
regulating vascular cellular homeostasis, vascular integrity, vasorelaxation, and local 
inflammation [12]. Dysfunction of the endothelium may result in pathogenic processes 
associated with a number of cardiovascular diseases such as atherosclerosis, hypertension, 
heart attack and stroke [13]. Because the endothelium constitutively expresses endothelial 
nitric oxide synthase (eNOS) and is exposed to NO derived from the inducible nitric oxide 
synthase (iNOS) isoform under inflammatory conditions [14]. NO increase has been found 
to coincide with an increase in protein S-nitrosylation, so it is an ideal tissue for studying S-
nitrosylation-dependent signals [15]. It is thought that the endogenous production of NO in 
the endothelium is not sufficient to inhibit endothelial cell activation during inflammation, 
and that higher concentrations of NO derived from the use of an exogenous NO donor, 
DETA-NONOate, is required for inducing higher levels of protein S-nitrosylation [16].
α-Lipoic acid (1, 2-dithiolane-3-pentanoic acid; LA) is a di-thiol antioxidant with diverse 
functions such as RNS quenching, anti-inflammatory activity [17], and may be therapeutic 
in mitochondria-related disorders [18, 19]. LA is also a cofactor for several enzymes 
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including pyruvate dehydrogenase complex (PDC) and α-ketoglutarate dehydrogenase 
complex (KDC), two mitochondrial enzymes involved in glucose metabolism and energy 
production. In a previous study, we reported that endogenous LA production is necessary for 
mouse embryo survival [20]. This result led us to propose that in addition to its antioxidant 
capacity, LA is essential for the maintenance of normal levels of energy metabolism [20]. 
We also found that LA increased the mitochondrial antioxidant capacity, and partially 
restored mitochondrial enzyme activity and increased ATP yield during sepsis in which an 
excess of NO had been produced [21]. Other investigators have also reported that the 
exposure of endothelial cells to small molecular S-nitrosothiols significantly down-regulates 
their mitochondrial function [22]. Therefore, we hypothesized that inflammation-induced 
excess NO production increases protein S-nitrosylation, which may result in diminished 
oxidative phosphorylation and decreased energy production in some mitochondrial enzymes. 
We propose that LA is able to alleviate mitochondrial dysfunction by regulating protein S-
nitrosylation, thus helping cells to retain their energy supply. In this study, we found that 
through alteration of protein S-nitrosylation, LA partially restores mitochondrial oxidative 
phosphorylation reserve capacity and ATP production. These findings shed light on a novel 
mechanism by which LA is able to rescue energy deficiency in inflammation-associated 
diseases, including low-grade chronic inflammation diseases, such as atherosclerosis and 
type 2 diabetes.
2. Materials and Methods
All animal protocols were reviewed and approved by the Ethics Committee of the University 
of North Carolina at Chapel Hill (Protocol number: 13-208-0).
2.1. Reagents
(Z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl) amino] diazen-1-ium-1, 2-diolate (DETA-
NONOate) was obtained from Cayman Chemical (Ann Arbor, MI). Protease inhibitor 
cocktail (Complete™ Mini EDTA-free protease inhibitor cocktail) was from Roche Applied 
Science (Indianapolis, IN). Antimycin A, Coenzyme A, cytochrome C, ferricytochrome C, 
carbonylcyanide p-triflouromethoxyphenyl-hydrazone (FCCP), oligomycin, potassium 
cyanide, S-methyl methanethiosulfonate (MMTS), rotenone, thiamine pyrophosphate, urea, 
CHAPS, neocuproine and cuprizone were all from Sigma-Aldrich (St. Louis, MO). 
Decylubiquinol was from Santa Cruz Biotechnology, Inc. (Dallas, TX); and R(+) α-lipoic 
acid (LA) was from Toronto Chemical Research (Toronto, Canada). NHS -Cy dyes and dye 
maleimides were from GE Healthcare (Piscataway, NJ).
2.2. Cell cultures
Primary aortic endothelial cells from C57BL/6J mice (Cell Biologics, Chicago, IL) and 
mouse brain endothelioma cells (bEnd.3, American Type Culture Collection, Manassas, VA) 
were used in these studies. The latter, an alternative source of endothelial cells, was used to 
compare the possible different responses to NS between the primary cells and the cell line. 
The primary cells and the brain cells were cultured in Complete Mouse Endothelial Cell 
Medium (Cell Biologics), and in Dulbecco's Modified Eagle Medium (DMEM) containing 
10% fetal bovine serum (Gibco, Langley, OK), respectively. Both cell types were maintained 
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in a humidified incubator gassed with 5% CO2, 95% air at 37° C. LA was dissolved in 100 
mM phosphate buffer (pH 7.2) after being converted into LA sodium salt. A concentration of 
50 μM of LA shows effective protection against oxidative stress in cell cultures [23-25]. 
Preparation of DETA-NONOate was based on the method by Dranka et al. [26], in which an 
appropriate dose to induce NS in endothelial cells (∼250 μM) was established. The amount 
of NO from DETA-NONOate was released at a constant rate (∼150 nM/min) during the first 
8 hours, and was monitored by absorbance spectroscopy. This concentration of DETA-
NONOate is capable of decreasing the oxygen consumption rate (OCR) [26]. Therefore, this 
is the concentration that we used for cell treatments in this study. Cell counting was 
performed using a Neubauer chamber, and the number of dead cells was determined by 
trypan-blue exclusion before and after treatment. The analysis was performed with 4 groups, 
5 samples per group, which were created as follows from cell cultures grown to ∼60% 
confluence: group 1: untreated cells (control group); group 2: cells in regular medium for 6 
hours followed by treatment with LA for 12 hours (LA group); group 3: cells treated with 
DETA-NONOate for 6 hours from time zero and then changed to fresh medium for 12 hours 
(NO group); and group 4: cells treated with DETA-NONOate for 6 hours, followed by a 
change to an LA-containing medium for 12 hours (NO+LA group).
2.3. Mitochondrial isolation and purity examination
Mitochondria were isolated from aortic endothelial cells using a Mitochondria Isolation Kit 
for cultured cells, the reagent-based method (Thermo Fisher Scientific, Rockford, IL, 
Product No. 89874) following the manufacturer's instructions. Certain critical points of 
purification procedure provided by other optimized protocols were applicable to our 
purification [27, 28]. Harvested cells were homogenized in ice-cold isolation buffer (100 
mM Tris–MOPS, 10 mM EGTA/Tris, 200 mM sucrose, pH 7.4). The homogenate was 
centrifuged for 10 min at 3,000 ×g at 4° C. The supernatants were collected in isolation 
buffer, and then centrifuged for 10 min at 10,000 ×g at 4° C. The resulting pellets were re-
suspended in ∼1 mL isolation buffer, kept on ice and used within 4 hours or stored at -80° C 
for later use.
The purity of the isolated mitochondria compared to cytosolic fractions was assesed via 
Western blot analysis for HSP60 or Tubulin and quantitated using Image Studio Light 
software (LICOR Biotechnologies, Lincoln, Nebraska). Protein concentrations were 
measured using the Thermo Scientific™ BCA Protein Assay Kit (Product No. 23225). A 
total of 20 μg of cytosolic proteins and 18.8 μg of mitochondrial proteins (the different 
loading amounts were normalized during quantitive calculation afterwards) were loaded on 
12% kD™ Mini-PROTEAN® TGX™ Precast gels (BioRad, Hercules, CA) and transferred 
onto nitrocellulose membranes. Membranes were blocked with 4% BSA for 1 hour. Protiens 
were detected with anti-HSP60 (Rabbit polyclonal, 1:10000, Abcam Cat# AB46798) and 
anti-tubulin (Mouse monoclonal anti-tubulin, beta III isoform, Chemicon Cat# MAB 1637), 
followed by secondary horseradish peroxidase (HRP)-conjugated antibody, either rabbit IgG 
(1:500) or mouse IgG (1:500), from Jackson ImmunoResearch Laboratories, Inc (West 
Grove, PA). Signals were detected with a chemiluminescence detection kit (Millipore).
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2.4. Determination of mitochondrial levels of antioxidant and oxidative stress
Isolated mitochondria prepared as described above were deproteinated with 5% 
trichloroacetic acid. The level of reduced glutathione (GSH), a major endogenous 
antioxidant in mitochondria, was determined with a Glutathione Assay Kit from Cayman 
Chemical. The protein concentration of each sample was determined using a bicinchoninic 
acid assay (BCA; Thermo Fisher Scientific). Mitochondrion oxidative stress was measured 
using 4-Hydroxynonenal (4-HNE) assay kit in accordance with manufacturer's specifications 
(Cell Biolabs, Inc. San Diego, CA).
Mitochondrial nitrate/nitrite (NOx) levels, as the stable metabolic end products of NO, were 
determined using a colorimetric assay kit (Cayman Chemical). The absorbance was read on 
a Biotek Synergy HT Multi-Mode microplate reader (Winooski, VT, USA) using a 
wavelength of 540 nm. Protein carbonyl content was assessed by using an OxiSelect Protein 
Carbonyl ELISA kit according to the manufacturer's instructions (Cell Biolabs, Inc.).
2.5. Determination of ATP production
ATP generation in the DETA-NONOate-treated primary aortic endothelial cells was 
analyzed by a luciferase substrate assay (Invitrogen, Carlsbad, CA). Briefly, the cells were 
homogenized and sonicated in ATP Assay Buffer provided by the company. After 
centrifugation at 12,000 ×g for 5 minutes at 4° C, the supernatant was removed and used for 
ATP measurement in an Orion Microplate Luminometer (Berthold Detection Systems, 
Titertek Instruments, Inc., Huntsville, AL). The amount of ATP was normalized to the 
protein concentration as determined by the BCA method.
2.6. Measurement of the oxygen consumption rate (OCR) and the extracellular acidification 
rate (ECAR)
OCR and ECAR were measured using the XF24 extracellular flux analyzer (Seahorse 
Bioscience, Billerica, MA) following the manufacturers' instructions. Briefly, primary aortic 
endothelial cells were seeded at a density of 5 × 104 cells per well, treated with 250 μM 
DETA-NONOate, followed by 50 μM LA. The cells were washed with PBS and incubated 
with bicarbonate-free (no buffering capacity) DMEM at 37° C for 1 hour. Measurements 
were taken sequentially, as the cells were incubated, with the following chemicals: (1) 
oligomycin (5 μg/mL), a reversible inhibitor of ATP synthase; (2) FCCP (5 μM), an electron 
uncoupler of ATP synthesis; and (3) antimycin A (40 μM), a complex III inhibitor. Basal 
levels of OCR and ECAR were obtained in the cultured cells without the additives.
2.7. Proteomic analysis
Confluent cells were washed four times with cold PBS, re-suspended in 500 μL of cold PBS 
supplemented with Complete™ protease inhibitor cocktail without EDTA, and spun at 2,000 
×g for 20 minutes at 4° C. Pelleted cells were re-suspended in 500 μL lysis buffer (8 M urea, 
4% CHAPS, 30 mM Tris, pH 8.5) supplemented with protease inhibitor cocktail, and then 
sonicated on ice three times, for 20 seconds each with 10 seconds rest. After centrifugation, 
the resulting supernatants were cleaned up using a 2D Clean-Up kit (GE Healthcare), 
according to the manufacturer's instructions. The final pellet was re-suspended either in lysis 
buffer or S-nitrosylated-labeling buffer (8 M urea, 4% CHAPS, 20 mM Tris, pH 7.3) and the 
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protein concentration was determined using a 2D Quant kit (GE Healthcare) as instructed by 
the manufacturer.
A modified fluorescence-switch method [29] was used to detect S-nitrosylated proteins as 
follows. Protein samples were re-suspended in S-nitrosylation-labeling buffer, MMTS was 
added to 100 μg of protein sample to produce a final concentration of 20 mM MMTS, and 
then incubated at room temperature for 1 hour while being protected from light. The samples 
were cleaned up as previously described [30] to remove unbound MMTS. Then the samples 
were re-suspended in S-nitrosylation-labeling buffer, and finally ascorbic acid was added to 
a final concentration of 100 mM (Figure 1). Samples were cleaned again and the resulting 
pellets were re-suspended in S-nitrosylation-labeling buffer, followed by the addition of 500 
pmol of Cy5-maleimide and flushed with nitrogen to decrease the possibility of protein 
oxidation. Samples were incubated at room temperature for 2 hours followed by incubation 
overnight at 4° C, protected from light.
An internal control (IC) was prepared by pooling equal amounts of protein (20 μg) from all 
control samples, which were labeled with 400 pmol/50 μg protein of NHS-Cy2. Aliquots 
from the IC were added to each gel. A 100 μg aliquot of each sample was processed as the 
S-nitrosylation sample without adding either MMTS or ascorbate. After clean-up, these 
samples were labeled with 400 pmol of NHS-Cy3 to determine total protein expression 
changes. The labeling reactions were carried out on ice for 30 minutes, protected from light. 
To quench the reaction, 1 μl of 10 mM lysine was added, and the reaction was incubated for 
an additional 10 minutes on ice in the dark. After labeling, corresponding samples were 
combined as shown in figure 1. An equal volume of 2X sample buffer (8 M urea, 4% 
CHAPS, 20 mg/mL DTT, 2% (v/v) IPG buffer 4–7 (GE Healthcare)) was added and the 
mixture was placed on ice for 15 minutes. Rehydration buffer (8M urea, 4% CHAPS, 2 
mg/mL DTT, 1% (v/v) IPG buffer 4-7) was added to a final volume of 250 μL.
2.8. Differential fluorescence 2D gel electrophoresis and image analysis
Differential fluorescence 2D gel electrophoresis was carried out as reported previously [31]. 
After electrophoresis, the gels were scanned with a Typhoon Trio+ (GE Healthcare). Gel 
images were analyzed as described [31] with Decyder 2D software Ver7.0 (GE Healthcare). 
The resulting images for S-nitrosylated proteins and total protein differential expression 
were analyzed separately, using the same internal control because the nitrosylated proteins 
within each group were assigned unique spot numbers, and the “total” protein spot numbers 
very often do not correlate to the same protein spot [31] due to the isoelectric point shift 
resulting from the different labels. Spot maps for each gel image (individual samples and 
internal control) were matched and an ANOVA (SAS Institute Inc., Cary, NC) comparison 
was performed between Control, LA, NO, and (NO+LA) for each spot. The extended data 
analysis (EDA) component of DeCyder 7.0 was used for principal component analysis 
(PCA) and hierarchical cluster analysis (HCA).
2.9. Protein identification by mass spectrometry (MS)
For protein identification purposes, approximately 400 μg of total protein consisting of equal 
contributions from each experimental group was separated by 2D gel electrophoresis for 
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spot picking. Matching protein spots between the pick gel and the analytical gels were 
picked using an Ettan spot picker (GE Healthcare), and digested with trypsin as previously 
described [32]. Proteins were identified using a 4800 MALDI TOF/TOF (Applied 
Biosystems (AB), Foster City, CA) mass spectrometer either at the UNC Proteomics Core 
Facility or the US EPA NHEERL Proteomics Research Core Facility. Mascot software 
(http://www.matrixscience.com/) was used to identify the proteins from background-
subtracted MALDI-MS and MS/MS data. MALDI-MS acquisition was followed by 
MALDI-MS/MS peptide sequencing, and the final protein identification was obtained using 
Protein Pilot 3.0 software (AB SCIEX, Framingham, MA), searching against the mouse 
(Mus musculus) sub-database of the SwissProt protein database (http://expasy.org/sprot/). 
Mass-selected MALDI-MS/MS spectra acquisition was performed to increase the protein 
sequence coverage. The reported proteins were identified based on at least two high-quality 
(95-99% peptide confidence scores in Protein Pilot) peptide sequence identifications made 
from the MS/MS data [32].
2.10. Alpha-ketoglutarate dehydrogenase (KDC) and complex III activities in mitochondria
KDC activity in isolated mitochondria was determined by monitoring the reduction of 
NAD+ at 340 nm. Briefly, isolated mitochondria were resuspended in buffer containing 25 
mM KH2PO4, 5 mM MgCl2, 0.5 mM EDTA, 0.1% (v/v) Triton X-100, 40 mM rotenone, 1.0 
mM NAD+, 0.2 mM thiamin pyrophosphate, and 0.1 mM Coenzyme A, pH 7. The 
mitochondria were sonicated in a water bath at room temperature for 30 seconds. A reaction 
mixture containing 5 mM MgCl2, 40 mM rotenone, 0.1 mM Coenzyme A, 0.2 mM thiamine 
pyrophosphate and 1 mM NAD+ were added to the mitochondrial medium to reach a final 
concentration of 0.4 mg mitochondrial protein/mL. The reaction was initiated by the 
addition of 2.5 mM α-ketoglutarate [33]. Complex III (ubiquinol-ferricytochrome C 
oxidoreductase; EC 1.10.2.2) activity in mitochondria was measured by following the 
increase in absorbance at 550 nm due to the reduction of ferricytochrome C [34]. The 
reaction mixture consisted of 25 mM KH2PO4, pH 7.4, 5 mM MgCl2, 2 mM KCN, 2.5 mg 
bovine serum albumin, 50 μM cytochrome C, and 4 mg rotenone.
Mitochondrial protein (25 μg) was added and the reaction was initiated by the addition of 60 
μM decylubiquinol, and the change in absorbance was monitored for 2 minutes. To 
determine antimycin-insensitive activity, the assay was repeated by adding 5 μg antimycin A 
to the reaction mixture. Antimycin A-sensitive complex III activity was calculated by 
comparing the resulting values with the initial rate, which was used as the base value. 
Enzyme activity was expressed as nmole of reduced cytochrome C per minute per mg of 
protein.
2.11. Statistical analysis
All data are reported as mean ± standard error of the mean (SEM). Values of p < 0.05 were 
considered to be statistically significant (95 % confidence limits). The significance of the 
effects of NO, LA, NO+LA and non-treated control groups were compared using one-way 
ANOVA.
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3 Results
3.1. Effect of LA on ATP production, mitochondrial function and redox status
We measured ATP levels in endothelial cells to determine the effect of excess NO on ATP 
production. We found that after treatment with DETA-NONOate ATP production decreased 
by 36% compared to control cells and that LA supplementation significantly restored ATP 
levels (Figure 2A); it is worth noting that LA alone did not affect ATP levels (Figure 2A). 
We measured 4-HNE and GSH concentrations in the mitochondria to evaluate whether or 
not administration of LA alters oxidative stress and can compensate for possible loss of 
mitochondrial antioxidant capacity due to RNS. Our results show that the mitochondrial 4-
HNE level increased by 57% whereas GSH decreased by ∼40% after NO treatment (p < 
0.01) and that LA-treated cells are less effected by NO. While LA alone did not significantly 
reduce 4-HNE and increase GSH levels without DETA-NONOate treatment, it suggests that 
the major effect of LA on 4-HNE and GSH production is mediated through RNS quenching 
(Figure 2B and 2C). In addition, the total NOx level in mitochondrial fraction was markedly 
elevated after treatment with DETA-NONOate. Supplement with LA significantly attenuated 
the elevated amount of NO (Figure 2D), reaching basal levels. Likewise, the ELISA results 
showed that cellular carbonyl levels increased by 71% in mitochondria isolated from NO-
treated cells as compared to control cells (p < 0.05), whereas addition of LA significantly 
reduced carbonyl formation (Figure 2E). Collectively, these data demonstrate that cells 
treated with NO have increased levels of RNS and ROS, which are opposed by LA 
supplementation, partially alleviating the stress.
To determine whether the mitochondrial reserve capacity was altered by excess NO and 
potentially regulated by LA we examined OCR and ECAR inprimary aortic endothelial cells 
and in brain endothelial cells treated with DETA-NONOate with and without LA 
supplementation. Mitochondrial reserve capacity was determined by uncoupling oxidative 
phosphorylation with the proton ionophore FCCP, followed by the addition of mitochondrial 
respiratory-chain complex inhibitors. First, oligomycin (5 μg/mL) was added to all samples 
to inhibit ATP synthase (complex V), and then FCCP (5 μM) was added. Exposure of 
endothelial cells to FCCP, which uncouples electron flow for ATP synthesis, stimulates 
respiration to the maximal level and provides an important indicator of mitochondrial 
reserve capacity (Figure 3A). Lastly, antimycin A (40 μM) was added to inhibit electron 
flow through complex III, which causes a dramatic suppression of OCR (Figure 3A). OCR 
was significantly decreased in cells exposed to NO (106 ± 11 pmoles/min) compared to 
OCR basal levels (182 ± 9 pmoles/min), whereas treatment with LA significantly offset this 
decline (163 ± 7 pmoles/min; p < 0.001). As indicated in Figure 3B, after the addition of 
FCCP, NO induced a 50% increase in ECAR compared to control (p < 0.01) while LA 
lowered ECAR by 22.5% (p < 0.05). OCR in brain endothelial cells showed comparable 
values (Figure 3C), suggesting that the effect of LA on OCR and ECAR is not exclusive to 
primary-cells.
To determine whether or not LA assists retaining mitochondrial energy production by 
altering protein S-nitrosylation, we examined changes in total protein levels and S-
nitrosylated proteins by a modified 2D DIGE-based biotin-switch method, in which both the 
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traditional 2D DIGE and the biotin-switch approaches were modified. Each 2D gel 
contained aliquots labeled for S-nitrosylation and total protein from a single sample, and a 
pooled internal control (Figure 1). S-nitrosylated proteins were recognized utilizing Cy5-
maleimide (Cy5-M), and changes in expression levels (total protein) were determined by 
labeling the proteins with NHS-Cy3. Since maleimide-labeled proteins often display shifts 
in gel migration due to charge changes, an internal protein control, labeled with NHS-Cy2, 
was used to normalize total protein expression and determine changes in migration patterns. 
As expected from the Cy5-M labeling, there was an isoelectric point (pI) shift relative to the 
same sample labeled for total protein with NHS-Cy3 (Figure 4, A-D). The resulting images 
for S-nitrosylated proteins and total protein changes were analyzed separately as described 
previously [29, 30].
All the reported results are statistically significant as determined by p < 0.05. Differential 
expression analysis revealed that 51 S-nitrosylated proteins presented expression level 
changes (Figure 5A), while total expression levels of 67 of the non S-nitrosylated proteins 
changed (Figure 5B). Fifteen (27%) of the 51 differentially S-nitrosylated proteins that were 
affected by NO were subsequently affected by the LA treatment. Of these, two-thirds of the 
proteins were characterized as having reduced S-nitrosylation levels resulting from LA 
treatment (addition of LA to the cell cultures in the presence of NO; data not shown). 
Addition of LA alone affected 26 (51%) of the S-nitrosylated proteins (Figure 5A). In 
contrast, 5 (10%) of the S-nitrosylated proteins that resulted from the effects of NO were not 
affected by LA supplementation (Figure 5A). From the 67 non-S-nitrosylated proteins 
displaying altered protein expression levels, 12 proteins (18%) that were affected by NO 
were also affected by LA (Figure 5B); and 37 proteins (56%) were affected by the LA 
treatment alone (Figure 5B). Finally, nine of the proteins (13%) that were altered by NO, 
were not affected by LA.
Statistically significant observations were further corroborated by hierarchical cluster 
analysis and principal component analysis (PCA). Principal component 1 (PC1) for S-
nitrosylated proteins (Figure 5C, top panel), which contains 55.5% of the variance between 
samples, confirmed that the addition of LA (LA or NO+LA) is the dominant component 
affecting protein S-nitrosylation. On the other hand, PC2, with 24.2% of variance, is 
between (NO+LA) and all other treatment groups. For differences in total protein 
expression, PC1 revealed a similar result with the addition of LA (either LA alone or NO
+LA), containing 63.6% of the variance between samples, confirming that LA was also the 
dominant component effecting protein alteration (Figure 5C, bottom panel). PC2 of total 
protein expression, with 21.3% of variance, was also between (NO+LA) and all other 
treatment groups. Similarly, hierarchical cluster analysis (Figure 5D) revealed that with both 
S-nitrosylation and total protein differences, LA and (NO+LA) were clustered together, and 
were separated from control and NO. Again, this suggests that the addition of LA was the 
dominant factor regulating protein S-nitrosylation.
Next, seven nitrosylated proteins and six proteins displaying significant changes in 
expression levels between the NO+LA and the NO groups were identified by MS (Table 1). 
Among the seven nitrosylated proteins, six proteins treated with (NO+LA) showed 
decreased S-nitrosylation and one protein showed increased S-nitrosylation levels at least 
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two-fold above that of NO alone. Interestingly, supplementation of NO-treated cells with LA 
decreased the nitrosylation of subunit I in complex III by 2.3-fold, and increased its 
expression by 2.0-fold. In addition, LA decreased nitrosylation of dihydrolipoyllysine 
succinyltransferase by 2.0-fold, a key component of the enzyme KDC.
3.3. Complex III and KDC activities
We found that complex III and KDC, which are primary energy transducting mitochondrial 
enzymes, are nitrosylated, and that the nitrosylation levels are reduced by adding LA. In 
order to further evaluate the impact of S-nitrosylation by NO and blocking of nitrosylation 
by LA on the activities of complex III and KDC, we measured their enzymatic activities in 
mitochondria isolated from aortic endothelial cells. The purity of mictochondrial factions 
was assessed by Western blot analysis and then quantitated by the Image software after 
nomolizing mitochondrial protein concentration to cytosol protein concentration. 
Mitochondrial and cytosolic fractions were immunoblotted with antibodies against HSP60, a 
mitochondrial matric protein, and β-tubulin, a cytosolic protein. The results show that 
distribution of β-tubulin was not able to be visualized in the mitochondrial fractions whereas 
intensity of HSP60 exhibited a marked increase in mitochondrial fractions Figure 6A and 
6B. The data clearly indicated a good enrichment of mitochondria following the purification. 
Complex III and KDC activities in the cells treated with the NO donor dropped 25% and 
37%, respectively, whereas LA significantly, restored partially both enzymatic activities (p < 
0.05) (Figures 6C and 6D). To determine whether the alteration of these enzymes' activities 
could be attributed to S-nitrosylation, we added the mitochondrial isolation buffer (pH 7.4) 
containing CuCl2 (10 μM) and ascorbic acid (0.1 mM) to isolated mitochondria, followed by 
incubation at room temperature for 30 min. It is well known that Cu+ is a nitrosylating agent 
[35, 36]. Ascorbic acid was added to reduce Cu++ to Cu+ and prevent Cu+ spontaneously 
oxidizing to Cu++. As figures 6E and 6F show, boith enzyme activities were augmented after 
adding Cu+ to the NO-treated group. We also found that in the presence of the specific Cu+ 
chelator neocuproine (NCP, 100 μM) the effect of Cu+ was completely abolished. However, 
adding the Cu++ chelator cuprizone (bis-cyclohexanone-oxalyldihydrazone, CPZ, 100 μM), 
had no effect (Figures 6F and 6F). These data show that the enzyme activities are affected by 
S-nitrosylation, likely through a Cu+-dependent mechanism. By comparing the activity 
values brought down by adding the NO donor and raised up by adding Cu+, we conclude 
that S-nitrosylation has a major impact in the decline of the enzymatic activities.
4. Discussion
In this study, we have demonstrated that a subunit of complex III in the electron transport 
chain, and dihydrolipoyllysine succinyltransferase, a subunit of KDC in the Krebs cycle, are 
susceptible to S-nitrosylation in response to NO treatment. In addition, S-nitrosylation of 
complex III and KDC coincide with a significant decrease in the activities of these two 
enzymes. These data demonstrate that S-nitrosylation decreases enzyme activities. Although 
canonical NO signaling occurs likely through its interaction with soluble guanylyl cyclase 
and controls cyclic guanosine monophosphate (cGMP)-dependent signaling, some 
investigations have suggested that protein S-nitrosation is an essential component of vascular 
(dys)function [6]. The endothelium is an ideal site for S-nitrosylation-dependent signals 
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because endothelial cells constitutively express the NO-producing enzyme endothelial nitric 
oxide synthase (eNOS), and under inflammatory conditions, it is also exposed to nitric 
oxide-derived from the inducible NOS isoform (iNOS) [14]. Our findings suport these 
observations. Importantly, our results reveal that LA supplementation significantly reduces 
S-nitrosylation on KDC and complex III, and partially restores their activities as well. These 
results disclose that regulation of protein S-nitrosylation is a novel redox regulatory 
mechanism of LA by which LA quenches NS to retain normal energy homeostasis. Our 
results agree with observations by other investigators. For instance, Murphy et al. found that 
KDC could be nitrosylated and that the nitrosylated form of the enzyme becomes inactive 
[9]. On the other hand, the fact that LA cannot completely abolish elevated levels of NO and 
fully restore the enzyme activitiy suggest that besides protein S-nitrosylation, other forms of 
regulations may exist. For example, cGMP dependent signal pathway and peroxynitrite 
could be part of these alternative mechanisms. It is well established that some biological 
activities including regulation of mitochondrial biogenesis [37] by NO are mediated via its 
primary receptor, the soluble guanylyl cyclase (sGC) [38]. In addition, NO reacts readily 
with superoxide to produce peroxynitrite, which can inhibit mitochondrial functions. 
Furthermore, our data show that the impairment of OCAR/ECAR and the mitochondrial 
reserve capacity after Deta-NONOate administration were readily reversible upon the 
addition of LA. These observations suggest that this rapid reversible reaction is not likely 
due to protein S-nitrosylation, since covalent modifications are not usually reversible. Since 
free NO can be converted into SNO and SNO can convert to NO, our current data do not 
support any effect over the other; i.e., which effect is mediated through free NO released 
from the NO donor or through S-nitrosylation modification.
We propose that diminished activities of complex III and KDC may lead to the decreased 
ATP production observed in our experiments for the following reasons: 1) complex III is a 
critical component of all primary energy transduction systems. It functions in maintaining 
the proton gradient, which provides ∼30% of body energy [39]. 2) KDC is a critical 
regulatory enzyme in the Krebs cycle [40], limiting the NADH production rate and oxidative 
phosphorylation [41]. It is thought that KDC plays a key role in bioenergetic deficit 
associated with oxidative stress [42]. 3) It is well-established that NO interacts with the 
mitochondrial respiratory chain by inhibiting cytochrome c oxidase (complex IV) and 
NADH-ubiquinone oxidoreductase (complex I) [43, 44]. And 4) mitochondrial proteins are 
constantly exposed to excess ROS [45]; therefore, are susceptible to oxidative damage, 
leading to energy deficiency [46]. Inhibition of mitochondrial complexes in the electron 
transport chain by excess NO leads to enhanced production of ROS [47]. Our data revealed 
that levels of 4-HNE– a biomarker of lipid peroxidation [48], carbonylated proteins– a 
biomarker of protein oxidation [49], and nitric oxide, were significantly increased whereas 
GSH levels were significantly decreased in the mithochodrial fractions. 4-HNE is derived 
from peroxidation of n-6 polyunsaturated fatty acids such as arachidonic and linoleic acids 
and it is one of the most abundant and active lipid peroxides. 4-HNE reacts with amino 
acids, such as cysteine, lysine or histidine, and forms stable adducts with proteins, leading to 
modulating activities of proteins. Carbonyl groups (aldehydes and ketones) are produced on 
protein side chains (especially of Pro, Arg, Lys, and Thr) where they are oxidized and 
increased. These alterations are partially restored by LA supplementation. The data suggest 
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that LA may provide mitocohondrial protection against NO damage, likely through 
regulation of GSH, a predominantly intra-mitochondrial antioxidant that protects 
mitochondrial complexes from NO-induced damage [50].
Our proteomics experiments indicate that most of the nitrosylated proteins affected by LA 
supplementation are involved in protein folding like protein disulfide-isomerase (PDI) and 
heat shock cognate 71 kDa (Hsc70). LA treatment affected the nitrosylation levels of PDI 
and Hsc70 by 4.6-fold increase and 3.0-fold decrease, respectively. PDI contains two 
thioredoxin domains that catalyze the formation, breakage, and rearrangement of disulfide 
bonds [51]. Hsc70 is involved in chaperoning unfolded proteins for degradation by both the 
ubiquitin-proteasome system and liposomes [52]. We do not know whether these 
observations coud provide more evidences to support McCarty's hypothesis. He postulated 
that LA could induce a heat shock response by assisting the formation of intra-molecular 
disulfide bonds in signaling proteins [53].
We have shown here that the expression of structural proteins including zyxin, prohibitin, 
vimentin, lamin A/C and actin is affected by excess NO, and changed by LA 
supplementation. We also observed that in response to excess NO, nitrosylation of actin and 
vimentin increased and appeared to decrease by LA supplementation. Zyxin is a protein 
attached to the cytoskeleton helping to organize function, dynamics and maintenance of 
actin fibers [54]. In endothelial cells, zyxin is activated in response to stretch, followed by 
translocation from the cytoskeleton to the nucleus [55]. Prohibitin (PHB) acts as a mediator 
of mitochondria shuttling in response to oxidative stress [56]. PHB also acts as a molecular 
chaperone stabilizing newly synthesized respiratory enzymes in mitochondria [57]. It seems 
clear that LA exerts multiple regulatory effects beyond direct ROS quenching. These 
regulatory functions may involve altering protein S-nitrosylation and regulation of the 
expression levels of some proteins that may be affected by S-nitrosative mechanisms. Our 
findings also show that mitochondrial proteins, regardless of their cytosolic or mitochondrial 
origin, and cytosolic proteins such as zyxin and Hsc70, undergo S-nitrosylation in the 
presence of elevated NO.
In summary, LA supplementation effectively restores mitochondrial enzyme activities of 
complex III and the α-ketoglutarate dehydrogenase complex inhibited by excess NO, mainly 
via S-nitrosylation. Regulation of these two enzymes, particularly via reducing S-
nitrosylation contributes to the protective effect observed. Our studies shed light on a new 
mechanism of antioxidant activity of LA, and suggest a strategy for the treatment of diseases 
in which chronic inflammation is involved.
Acknowledgments
The authors thank Dr. Rosaline Coleman for insightful suggestions and Dr. Carol Parker for critically reviewing the 
manuscript. This manuscript has been reviewed by the US Environmental Protection Agency, NHEERL and 
approved for publication. The authors would like to thank Drs. P.R. Kodavanti and J. Royland for their constructive 
comments. Approval does not signify that the contents reflect the views of the US EPA, nor does mention of trade 
names or commercial products constitute endorsement or recommendation for use.
This work was supported by Amercan Heart Association grant #13GRNT17120056 (to X. Y.).
Hiller et al. Page 12
Biochim Biophys Acta. Author manuscript; available in PMC 2017 February 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
References
1. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of 
endothelium-derived relaxing factor. Nature. 1987; 327:524–526. [PubMed: 3495737] 
2. Palmer RM, Bridge L, Foxwell NA, Moncada S. The role of nitric oxide in endothelial cell damage 
and its inhibition by glucocorticoids. Br J Pharmacol. 1992; 105:11–12. [PubMed: 1596673] 
3. Iovine NM, Pursnani S, Voldman A, Wasserman G, Blaser MJ, et al. Reactive nitrogen species 
contribute to innate host defense against Campylobacter jejuni. Infect Immun. 2008; 76:986–993. 
[PubMed: 18174337] 
4. Behr-Roussel D, Rupin A, Simonet S, Bonhomme E, Coumailleau S, et al. Effect of chronic 
treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-
arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. 
Circulation. 2000; 102:1033–1038. [PubMed: 10961969] 
5. Cromheeke KM, Kockx MM, De Meyer GR, Bosmans JM, Bult H, et al. Inducible nitric oxide 
synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. 
Cardiovasc Res. 1999; 43:744–754. [PubMed: 10690346] 
6. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosylation: purview and 
parameters. Nat Rev Mol Cell Biol. 2005; 6:150–166. [PubMed: 15688001] 
7. Moncada S. Nitric oxide and cell respiration: physiology and pathology. Verh K Acad Geneeskd 
Belg. 2000; 62:171–179. discussion 179-181. [PubMed: 10905118] 
8. Lima B, Forrester MT, Hess DT, Stamler JS. S-nitrosylation in cardiovascular signaling. Circ Res. 
2010; 106:633–646. [PubMed: 20203313] 
9. Sun J, Murphy E. Protein S-nitrosylation and cardioprotection. Circ Res. 2010; 106:285–296. 
[PubMed: 20133913] 
10. Luedike P, Hendgen-Cotta UB, Sobierajski J, Totzeck M, Reeh M, et al. Cardioprotection through 
S-nitros(yl)ation of macrophage migration inhibitory factor. Circulation. 2012; 125:1880–1889. 
[PubMed: 22415145] 
11. Diers AR, Broniowska KA, Hogg N. Nitrosative stress and redox-cycling agents synergize to cause 
mitochondrial dysfunction and cell death in endothelial cells. Redox Biol. 2013; 1:1–7. [PubMed: 
24024132] 
12. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, et al. Endothelial cells in physiology 
and in the pathophysiology of vascular disorders. Blood. 1998; 91:3527–3561. [PubMed: 
9572988] 
13. Jiang F, Drummond GR, Dusting GJ. Suppression of oxidative stress in the endothelium and 
vascular wall. Endothelium. 2004; 11:79–88. [PubMed: 15370067] 
14. Griffith OW, Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev 
Physiol. 1995; 57:707–736. [PubMed: 7539994] 
15. Marshall HE, Stamler JS. Nitrosative stress-induced apoptosis through inhibition of NF-kappa B. J 
Biol Chem. 2002; 277:34223–34228. [PubMed: 12091382] 
16. Qian J, Fulton DJ. Exogenous, but not Endogenous Nitric Oxide Inhibits Adhesion Molecule 
Expression in Human Endothelial Cells. Front Physiol. 2012; 3:3. [PubMed: 22279436] 
17. Packer L, Witt EH, Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol 
Med. 1995; 19:227–250. [PubMed: 7649494] 
18. Reed LJ. From lipoic acid to multi-enzyme complexes. Protein Sci. 1998; 7:220–224. [PubMed: 
9514279] 
19. Tirosh O, Shilo S, Aronis A, Sen CK. Redox regulation of mitochondrial permeability transition: 
effects of uncoupler, lipoic acid and its positively charged analog LA-plus and selenium. 
Biofactors. 2003; 17:297–306. [PubMed: 12897451] 
20. Yi X, Maeda N. Endogenous production of lipoic acid is essential for mouse development. Mol 
Cell Biol. 2005; 25:8387–8392. [PubMed: 16135825] 
21. Hiller S, DeKroon R, Xu L, Robinette J, Winnik W, et al. alpha-Lipoic acid protects mitochondrial 
enzymes and attenuates lipopolysaccharide-induced hypothermia in mice. Free Radic Biol Med. 
71:362–367.
Hiller et al. Page 13
Biochim Biophys Acta. Author manuscript; available in PMC 2017 February 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
22. Diers AR, Broniowska KA, Darley-Usmar VM, Hogg N. Differential regulation of metabolism by 
nitric oxide and S-nitrosothiols in endothelial cells. Am J Physiol Heart Circ Physiol. 2011; 
301:H803–812. [PubMed: 21685262] 
23. Zhang WJ, Wei H, Hagen T, Frei B. Alpha-lipoic acid attenuates LPS-induced inflammatory 
responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad Sci 
U S A. 2007; 104:4077–4082. [PubMed: 17360480] 
24. Shay KP, Michels AJ, Li W, Kong AN, Hagen TM. Cap-independent Nrf2 translation is part of a 
lipoic acid-stimulated detoxification stress response. Biochim Biophys Acta. 2012; 1823:1102–
1109. [PubMed: 22521877] 
25. Smith JR, Thiagaraj HV, Seaver B, Parker KK. Differential activity of lipoic acid enantiomers in 
cell culture. J Herb Pharmacother. 2005; 5:43–54. [PubMed: 16520297] 
26. Dranka BP, Hill BG, Darley-Usmar VM. Mitochondrial reserve capacity in endothelial cells: The 
impact of nitric oxide and reactive oxygen species. Free Radic Biol Med. 2010; 48:905–914. 
[PubMed: 20093177] 
27. Clayton DA, Shadel GS. Isolation of mitochondria from cells and tissues. Cold Spring Harb 
Protoc. 2014; 10:1109–1111.
28. Wieckowski MR, Giorgi C, Lebiedzinska M, Duszynski J, Pinton P. Isolation of mitochondria-
associated membranes and mitochondria from animal tissues and cells. Nat Protoc. 2009; 4:1582–
90. [PubMed: 19816421] 
29. Jaffrey SR, Snyder SH. The biotin switch method for the detection of S-nitrosylated proteins. Sci 
STKE. 2001; 2001:pl1.
30. DeKroon RM, Robinette JB, Osorio C, Jeong JS, Hamlett E, et al. Analysis of protein 
posttranslational modifications using DIGE-based proteomics. Methods Mol Biol. 2012; 854:129–
143. [PubMed: 22311757] 
31. DeKroon RM, Osorio C, Robinette JB, Mocanu M, Winnik WM, et al. Simultaneous detection of 
changes in protein expression and oxidative modification as a function of age and APOE genotype. 
J Proteome Res. 2011; 10:1632–1644. [PubMed: 21210719] 
32. Winnik WM, Dekroon RM, Jeong JS, Mocanu M, Robinette JB, et al. Analysis of proteins using 
DIGE and MALDI mass spectrometry. Methods Mol Biol. 2012; 854:47–66. [PubMed: 22311753] 
33. Nulton-Persson AC, Szweda LI. Modulation of mitochondrial function by hydrogen peroxide. J 
Biol Chem. 2001; 276:23357–23361. [PubMed: 11283020] 
34. Trounce IA, Kim YL, Jun AS, Wallace DC. Assessment of mitochondrial oxidative 
phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. 
Methods Enzymol. 1996; 264:484–509. [PubMed: 8965721] 
35. Al-Sa'doni HH, Megson IL, Bisland S, Butler AR, Flitney FW. Neocuproine, a selective Cu(I) 
chelator, and the relaxation of rat vascular smooth muscle by S-nitrosothiols. Br J Pharmacol. 
1997; 121:1047–1050. [PubMed: 9249237] 
36. Singh RJ, Hogg N, Joseph J, Kalyanaraman B. Mechanism of nitric oxide release from S-
nitrosothiols. J Biol Chem. 1996; 271:18596–18603. [PubMed: 8702510] 
37. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, et al. Mitochondrial biogenesis in mammals: 
the role of endogenous nitric oxide. Science. 2003; 299:896–899. [PubMed: 12574632] 
38. Wobst J, Kessler T, Dang TA, Erdmann J, Schunkert H. Role of sGC-dependent NO signalling and 
myocardial infarction risk. J Mol Med (Berl). 93:383–394. [PubMed: 25733135] 
39. Crofts AR. The cytochrome bc1 complex: function in the context of structure. Annu Rev Physiol. 
2004; 66:689–733. [PubMed: 14977419] 
40. Cooney GJ, Taegtmeyer H, Newsholme EA. Tricarboxylic acid cycle flux and enzyme activities in 
the isolated working rat heart. Biochem J. 1981; 200:701–703. [PubMed: 7342978] 
41. Tretter L, Adam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of 
[alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J 
Neurosci. 2000; 20:8972–8979. [PubMed: 11124972] 
42. Tretter L, Adam-Vizi V. Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative 
stress. Philos Trans R Soc Lond B Biol Sci. 2005; 360:2335–2345. [PubMed: 16321804] 
Hiller et al. Page 14
Biochim Biophys Acta. Author manuscript; available in PMC 2017 February 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
43. Huttemann M, Lee I, Pecinova A, Pecina P, Przyklenk K, et al. Regulation of oxidative 
phosphorylation, the mitochondrial membrane potential, and their role in human disease. J 
Bioenerg Biomembr. 2008; 40:445–456. [PubMed: 18843528] 
44. Zhang J, Jin B, Li L, Block ER, Patel JM. Nitric oxide-induced persistent inhibition and 
nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in lung 
endothelial cells. Am J Physiol Cell Physiol. 2005; 288:C840–849. [PubMed: 15561762] 
45. Barreiro E, Comtois AS, Gea J, Laubach VE, Hussain SN. Protein tyrosine nitration in the 
ventilatory muscles: role of nitric oxide synthases. Am J Respir Cell Mol Biol. 2002; 26:438–446. 
[PubMed: 11919080] 
46. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007; 
100:460–473. [PubMed: 17332437] 
47. Musatov A, Robinson NC. Susceptibility of mitochondrial electron-transport complexes to 
oxidative damage. Focus on cytochrome c oxidase. Free Radic Res. 2012; 46:1313–1326. 
[PubMed: 22856385] 
48. Zhang X, Wang Z, Li J, Gu D, Li S, et al. Increased 4-hydroxynonenal formation contributes to 
obesity-related lipolytic activation in adipocytes. PLoS One. 2013; 8:e70663. [PubMed: 
23940618] 
49. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as 
biomarkers of oxidative stress. Clin Chim Acta. 2003; 329:23–38. [PubMed: 12589963] 
50. Brealey D, Singer M. Mitochondrial Dysfunction in Sepsis. Curr Infect Dis Rep. 2003; 5:365–371. 
[PubMed: 13678565] 
51. Pihlajaniemi T, Helaakoski T, Tasanen K, Myllyla R, Huhtala ML, et al. Molecular cloning of the 
beta-subunit of human prolyl 4-hydroxylase. This subunit and protein disulphide isomerase are 
products of the same gene. EMBO J. 1987; 6:643–649. [PubMed: 3034602] 
52. Meimaridou E, Gooljar SB, Ramnarace N, Anthonypillai L, Clark AJ, et al. The cytosolic 
chaperone Hsc70 promotes traffic to the cell surface of intracellular retained melanocortin-4 
receptor mutants. Mol Endocrinol. 2011; 25:1650–1660. [PubMed: 21719532] 
53. McCarty MF. Versatile cytoprotective activity of lipoic acid may reflect its ability to activate 
signalling intermediates that trigger the heat-shock and phase II responses. Med Hypotheses. 2001; 
57:313–317. [PubMed: 11516223] 
54. Macalma T, Otte J, Hensler ME, Bockholt SM, Louis HA, et al. Molecular characterization of 
human zyxin. J Biol Chem. 1996; 271:31470–31478. [PubMed: 8940160] 
55. Suresh Babu S, Wojtowicz A, Freichel M, Birnbaumer L, Hecker M, et al. Mechanism of stretch-
induced activation of the mechanotransducer zyxin in vascular cells. Sci Signal. 2012; 5:ra91. 
[PubMed: 23233529] 
56. Lee H, Arnouk H, Sripathi S, Chen P, Zhang R, et al. Prohibitin as an oxidative stress biomarker in 
the eye. Int J Biol Macromol. 2010; 47:685–690. [PubMed: 20832420] 
57. Nijtmans LG, de Jong L, Artal Sanz M, Coates PJ, Berden JA, et al. Prohibitins act as a membrane-
bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 2000; 19:2444–2451. 
[PubMed: 10835343] 
Hiller et al. Page 15
Biochim Biophys Acta. Author manuscript; available in PMC 2017 February 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Highlights
• We identified new antioxidant protein targets for α-lipoic acid activity.
• α-lipoic acid supplementation restores mitochondrial enzymatic activities
• α-lipoic acid improves ATP generation inhibited by nitrosative stress.
• Our findings disclose a novel redox regulatory function of α-lipoic acid.
• Our data suggest a novel strategy for treatment of inflammation-related 
diseases.
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Figure 1. Experimental design
Protein preparations from four samples were used for SNO analysis: untreated samples used 
as the Control group; samples from cells treated with nitric oxide (NO group); samples from 
cells treated with LA (LA group); and samples from cells that were treated with NO, 
followed by treatment with LA (NO+LA). Each group was divided into three fractions: 
fraction one consisted of 20 μL from each sample, these samples were pooled, and labeled 
with NHS-Cy2 to develop an internal control (IC). This IC was used for image 
normalization, and differential expression analysis; fraction two, consisted of 100 μg of total 
protein sample that was treated first with MMTS to block free sulfhydryl groups, then 
treated with ascorbate to remove the NO groups, and then labeled with Cy5-maleimide, to 
label the free -SH groups that resulted from the ascorbate treatment. This fraction provides a 
red color when scanned with the Typhoon TRIO+; and fraction three (SHAM) consisting of 
100 μg of sample and treated as fraction two, without adding MMTS, or ascorbate. This 
fraction was labeled with NHS-Cy3, and used to determine the total amount of protein. In 
principle, it is expected that every protein that was initially nitrosylated would provide a 
fluorescent red color after the treatment. After sample treatment and labeling, the proteins 
were fractionated by 2D Fluorescent gel electrophoresis. The differences in total protein 
expression, and protein nitrosylation were determined with the Decyder 2D software 
{DeKroon et al, 2011—Ref 29}.
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Figure 2. LA increased ATP production and mitochondrial GSH levels
A) ATP production in primary aortic endothelial cells treated with the NO donor, DETA 
NONOate, in the presence or absence of LA. Each group was collected from 3 independent 
experiments. B) Mitochondrial 4-HNE level was increased after NO treatment and that LA-
treated cells significantly offset this effect of NO. C) Reduced glutathione (GSH) levels in 
mitochondria isolated from the NO donor-treated cells with or without LA. D) Total NOx 
level in mitochondrial fraction was markedly elevated after treatment with DETA-NONOate 
whereas LA supplementation significantly attenuated the elevated amount of NOx. E) 
Cellular carbonyl levels increased by 71% in mitochondria isolated from NO-treated cells as 
compared to control cells (p < 0.05), whereas addition of LA significantly reduced carbonyl 
formation. Data from five independent experiments are expressed as the mean ±SEM.
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Figure 3. LA restored OCR and ECAR, inhibited by nitrosative stress in endothelial cells
A) Oxygen consumption rates (OCR), B) Extracellular acidification rate (ECAR) in the 
primary aortic endothelial cells, and C) OCR in brain endothelial cells, were measured using 
a Seahorse extracellular flux analyzer. The cells were treated with DETA NONOate (final 
concentration 250 μM) for 6 hour and then fed LA (50 μM) for 12 hours, followed by the 
sequential addition of oligomycin, FCCP, and antimycin A as shown. Data are shown as 
means SEM of n=18 wells (each group) collected from 3 independent experiments. The 
OCR and ECAR values are normalized by cell numbers.
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Figure 4. Overlaid images of SNO proteins
Changes in protein S-nitrosylation as well as changes in total protein expression were 
analyzed using a modification of the Biotin-switch method. The whole process was 
illustrated in Figure 1, and here we show representative images of 2D gels containing S-
nitrosylated and non-nitrosylated proteins, and visual evidence that the Cy-maleimide 
labeling of the modified proteins induces pI shifts. A) NO+LA: Cy2 (Blue) is used to 
labeled LA-treated samples used as control; Cy3 (Green) shows proteins treated with NO
+LA; Cy5-M (Red) shows nitrosylated proteins. B) Grayscale of Cy3 (Green), i.e., proteins 
treated with NO+LA. C) NO+LA: Cy3 (Green) is used to label proteins treated with NO
+LA; Cy5-M (Red) is nitrosylated proteins. D) Grayscale of Cy5 (Red), i.e., Nitrosylated 
proteins. These images demonstrate ‘matching’ between total protein and the internal 
control, while Cy5-M produces a shift in isoelectric point as exemplified by the spots in 
oval.
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Figure 5. 
Total numbers and categories of mass spectrometry-identified A) S-nitrosylated proteins; 
and B) differentially expressed proteins. C) Principal component analysis (PCA). (Top 
panel) PCA for SNO proteins. Principal component 1 (PC1) demonstrates that the addition 
of LA (LA or NO+LA) was the dominant component effecting protein S-nitrosylation. The 
second principle component (PC2) was between NO+LA and all other treatment groups. 
(Bottom panel) PCA for total protein expression. The addition of LA (LA or NO+LA) was 
again the first principal component effecting protein expression. PC2 was between NO+LA 
and all other treatment groups. D) Hierarchical cluster analysis. With both S-nitrosylated 
(SNO) and total protein differences LA and NO+LA were clustered together, separate from 
control and NO which were also clustered together.
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Figure 6. Activities of complex III and alpha-ketoglutarate dehydrogenase (KDC) in 
mitochondria isolated from the nitric oxide donor-treated cells with or without LA
A) Purity of mitochondrial preparations assessed by Western blot. Ten randomly selected 
cytosolic (a and c) and mitochondrial (b and d) fractions were immunoblotted with 
antibodies against β-Tubulin and HSP60. B) The amounts of the proteins were quantified by 
Image Studio Light software. Results are given as band intensities of Western blot signals, 
represented as mean ± SEM. C) Complex III activity was expressed as nmole of reduced 
cytochrome C/minute per mg of protein. D) KDC activity was determined by monitoring 
NAD+ reduction at 340 nm. E and F) Activities of complex III and KDC were increased 
after adding Cu+ to the NO-treated group. In the presence of the specific Cu+.chelator 
neocuproine (NCP), the effect of Cu+ was completely abolished. However, adding the Cu++ 
chelator cuprizone (CPZ), had no effect on the enzyme activities. Data from five 
independent experiments are expressed as the mean ±SEM.
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Table 1
S-Nitrosylated proteins that were affected by addition of LA
spot no. Protein identity Ratio ANOVA Matched Peptides
771 Heat shock cognate 71 kDa protein -3.0 0.043 8
880 Isoform C of Prelamin-A/C -1.25 0.045 6
1097 Protein Prss3 +3.1 0.008 23
1104 Dihydrolipoyllysine succinyltrnsferae of KDC -2.0 0.037 24
1292 Cytochrome b-c1 complex subunit I -2.3 0.024 15
1494 β-Actin -2.0 0.034 16
2031 Prohibitin -2.2 0.046 12
LA: lipoic acid
KDC: alpha-ketoglutarate dehydrogenase complex
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Table 2
Proteins that displayed changes in expression affected by LA
spot no. Protein identity Ratio ANOVA Matched Peptides
577 Zyxin -2.1 0.033 8
741 Heat shock 70 kDa protein 5 -2.6 0.025 32
1048 protein disulfide-isomerase +4.6 0.039 21
1150 Vimentin -3.2 0.03 36
1319 Ribonuclease inhibitor isoform a +1.4 0.007 6
1327 Cytochrome b-c1 complex subunit I +2.0 0.026 15
LA: lipoic acid
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